Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 3/20 | 0.43 |
| ▸ | SGPL1 | O95470 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | PAM | P19021 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2905259 | 1.00 | DGKA (0.43) | DGKAELANESGPL1TDP1PAM | |
| SCHEMBL9697296 | 0.94 | DGKA (0.41) | DGKAELANESGPL1TDP1ALDH1A1 | |
| SCHEMBL516267 | 0.93 | KDM4E (0.51) | DGKAELANESGPL1PAMKDM4E | |
| SCHEMBL9232006 | 0.93 | KDM4E (0.51) | DGKAELANESGPL1PAMKDM4E | |
| SCHEMBL31190161 | 0.86 | ALDH1A1 (0.45) | DGKAELANESGPL1TDP1KDM4E | |
| SCHEMBL31208064 | 0.86 | KDM4E (0.45) | DGKAELANESGPL1KDM4EALDH1A1 | |
| SCHEMBL2423289 | 0.85 | NR4A1 (0.43) | DGKAELANETDP1PAMNR4A1 | |
| SCHEMBL5155355 | 0.85 | DGKA (0.41) | DGKAELANETDP1PAMALDH1A1 | |
| SCHEMBL21916175 | 0.84 | PNPO (0.39) | TDP1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL31746185 | 0.82 | PNPO (0.40) | SGPL1TDP1KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 806 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117858620-A | Antimicrobial combinations | 西姆莱斯有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-115957225-A | MMP-1 expression inhibitor, skin external composition and application thereof | 广东植肤生物科技有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-112022730-A | Agent combination for skin care | 西安博鸿生物技术有限公司 | 2020-12-04 | — | — | CN | claimed |
| CN-111904891-A | Water-in-oil composition | 西安博鸿生物技术有限公司 | 2020-11-10 | — | — | CN | claimed |
| EP-4122443-B1 | COSMETIC COMPOSITION WITH SILICONE-MODIFIED POLYSACCHARIDE | SHINETSU CHEMICAL CO (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12611370-B2 | Microemulsion composition and cosmetic containing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-28 | — | — | US | disclosed |
| US-12600821-B2 | Crosslinked organosilicon resin, a method for producing same, and a cosmetic | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-14 | — | — | US | disclosed |
| EP-4717725-A1 | ORGANOPOLYSILOXANE AND COSMETIC CONTAINING ORGANOPOLYSILOXANE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-01 | — | — | EP | disclosed |
| EP-4714430-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-25 | — | — | EP | disclosed |
| EP-4706634-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-11 | — | — | EP | disclosed |
| EP-4706633-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-11 | — | — | EP | disclosed |
| EP-4702970-A1 | COSMETIC CONTAINING AMINO ALCOHOL-MODIFIED SILICONE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-0450094-B1 | HYDROPHILIC POLYMER-SILICATE MINERAL COMPOSITE AND ITS USE | SHISEIDO CO LTD (JP) | 1996-10-02 | — | — | EP | disclosed |
| US-5538728-A | SKIN ULCER MEDICINE OF GELS OR COMPOSITES WITH POLYMER GELS AND LAXATIVES | SHISEIDO COMPANY, LTD. (JP) | 1996-07-23 | — | — | US | disclosed |
| EP-0688559-A1 | Skin anti-ageing composition | SHISEIDO COMPANY LIMITED (JP) | 1995-12-27 | — | — | EP | disclosed |
| EP-0506961-B1 | EXTERNAL PREPARATION FOR SKIN | SHISEIDO CO LTD (JP) | 1995-12-20 | — | — | EP | disclosed |
| US-5415875-A | Applying hydrolyzed shell membrane and tocopherol derivative; aging and oxidation resistance | SHISEIDO CO., LTD. (JP) | 1995-05-16 | — | — | US | disclosed |
| EP-0601698-A1 | Topical composition comprising tocopherol | SHISEIDO COMPANY LIMITED (JP) | 1994-06-15 | — | — | EP | disclosed |
| EP-0506961-A1 | EXTERNAL PREPARATION FOR SKIN | SHISEIDO COMPANY LIMITED (JP) | 1992-10-07 | — | — | EP | disclosed |
| EP-0450094-A1 | HYDROPHILIC POLYMER-SILICATE MINERAL COMPOSITE AND ITS USE | SHISEIDO COMPANY LIMITED (JP) | 1991-10-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12611370-B2 | Microemulsion composition and cosmetic containing the same | MGLL, SGMS2, MAN2B1 | DGKA 1331/4885ELANE 848/4885SGPL1 42/4885 |
| US-12600821-B2 | Crosslinked organosilicon resin, a method for producing same, and a cosmetic | DEGS1, HACL2, GAR1 | DGKA 870/4885ELANE 1163/4885SGPL1 86/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.